PM touts deal for 26K doses of COVID-19 therapeutic, seeks to temper vaccine expectations


The federal government has signed a deal to secure up to 26,000 doses of a COVID-19 therapeutic drug from Eli Lilly, with the option to receive thousands more, Prime Minister Justin Trudeau announced Tuesday. He also sought to temper Canadians’ expectations around the timing and rollout of an eventual vaccine or vaccines to immunize against the novel coronavirus. “To keep Canadians safe, we need access to as many potential vaccines and treatments as possible,” Trudeau said during his Rideau Cottage address on Tuesday. Trudeau said that, while there has been promising news about some vaccine candidates that Canada will receive millions of doses of, it will still be months before vaccines are expected to arrive on Canadian soil.

Notifications - Subscriptions
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x